William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Reiterates Outperform Rating on Korn/Ferry (KFY) following Q3 results
-
William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): "remain bullish here"
-
William Blair Reiterates Outperform Rating on ARS Pharmaceuticals Inc (SPRY) following Q4 results
-
William Blair: '$15 move in oil can cause FCF yield to more than double'
-
Korro Bio raises $85 million in oversubscribed private placement
-
Korro Announces Oversubscribed $85 Million Private Placement
-
William Blair Starts Jade Biosciences (JBIO) at Outperform
-
William Blair Reiterates Outperform Rating on Amprius Technologies (AMPX): "best-positioned arms dealer to supply this burgeoning industry"
-
William Blair Reiterates Outperform Rating on Stitch Fix, Inc. (SFIX): "Pullback Creates Compelling Entry Point"
-
Holding(s) in Company
-
William Blair Reiterates Outperform Rating on Crescent Energy (CRGY) following convertible notes offering announcement
-
William Blair Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Market Perform, Removed from Analyst Conviction List
-
William Blair: 'we believe Marvell is well positioned to grab its fair share of the AI infrastructure wallet'
-
SCHMID Group N.V. announces closing of the second tranche of its USD 30 million convertible notes financing
-
Ingram Micro prices secondary offering at $22.25 per share
-
Ingram Micro Holding Corporation Announces Pricing of Secondary Offering of Common Stock by its Principal Stockholder.
-
MiniMed prices IPO at $20 per share, raising $560 million
-
MiniMed announces pricing of initial public offering
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 485BPOS WILLIAM BLAIR FUNDS
-
William Blair Reiterates Outperform Rating on BJ's Wholesale (BJ), but "we expect BJ’s will deliver first-quarter comps below 2%"
-
William Blair Reiterates Market Perform Rating on WillScot Holdings Corp (WSC): "we expect project activity to remain depressed"
-
William Blair Reiterates Market Perform Rating on Zillow (Z) following stock buyback announcements
-
Analysis-Down but not out: Emerging markets could endure Middle East shocks, investors say
-
William Blair Reiterates Outperform Rating on Sight Sciences Inc. (SGHT) following earnings call
-
William Blair Reiterates Outperform Rating on Monolithic Power Systems (MPWR)
-
William Blair Reiterates Outperform Rating on Compass Therapeutics (CMPX)
-
William Blair Reiterates Outperform Rating on USA Rare Earth Inc (USAR): "We believe shares could trade at a 10x multiple"
-
William Blair Reiterates Market Perform Rating on Altimmune (ALT)
-
William Blair Reiterates Outperform Rating on Manhattan Associates, Inc. (MANH) following stock buyback announcement
-
William Blair Reiterates Outperform Rating on Stryker (SYK): "upside potential from international and M&A"
-
William Blair Reiterates Outperform Rating on Lennox International (LII): "believe the HVAC market is finding a bottom"
-
William Blair Reiterates Outperform Rating on Riley Exploration Permian Inc. (REPX) following earnings
-
Medline prices secondary offering at $41 per share
-
Medline Inc. announces pricing of secondary offering of class A common stock
-
William Blair Reiterates Outperform Rating on Real Brokerage Inc. (REAX)
-
William Blair Reiterates Outperform Rating on Latham Group Inc. (SWIM)
-
William Blair Reiterates Market Perform Rating on Abercrombie & Fitch (ANF): "we see shares holding wide trading range"
-
Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang
-
William Blair Reiterates Outperform Rating on MP Materials (MP): "Key player" amid strained U.S.-China relations
-
William Blair Reiterates Outperform Rating on Accenture plc (ACN) following acquisition announcement
-
William Blair Reiterates Outperform Rating on Korn/Ferry (KFY): Q3 "should be fine"
-
William Blair Reiterates Outperform Rating on Carnival Corporation (CCL) "given the muted valuation"
-
William Blair Reiterates Outperform Rating on Booz Allen Hamilton (BAH): "Regaining its footing"
-
William Blair Reiterates Outperform Rating on Harrow Health (HROW): "We believe the long-term growth outlook is attractive"
-
CoStar Group stock rises after CEO buys $2.5M in shares
-
William Blair Reiterates Outperform Rating on CoStar Group (CSGP) amid CEO buy
-
William Blair Reiterates Outperform Rating on Aehr Test Systems (AEHR); "We find this order incremental to our thesis"
-
William Blair Reiterates Outperform Rating on Ingram Micro (INGM); "Xvantage platform is a key differentiator"
-
CrossCountry Consulting Acquires CNM, Expanding West Coast Presence

